SAM #SSDS-11-4-2026-NCIRD-ID

CDC Market Research for a California EHR Site Supporting VISION 2.0 Surveillance

The Centers for Disease Control and Prevention is seeking market information on a California health system that can support respiratory pathogen surveillance through its VISION 2.0 network. - Government buyer: Centers for Disease Control and Prevention (CDC), CDC Office of Acquisition Services; program area: National Center for Immunization and Respiratory Diseases (NCIRD). The listed contact is Debra A. Baker. - Requested service: A California-based integrated health care system to serve as an electronic health record (EHR) site in CDC’s VISION 2.0 surveillance network. - Provide linked, longitudinal medical, laboratory, pharmacy, vaccination, immunization-registry, claims, and outcomes data across emergency and urgent care, inpatient, and intensive care settings. - Support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research. - Notable requirements: Deliver secure, validated, standardized, analysis-ready individual-level data; collaborate on shared network protocols and quality assurance; and demonstrate relevant research and analytics capability. - Potential expanded work includes maternal-infant record linkage, additional COVID-19, RSV, and other pathogen data, site analyses, and participation in a network-wide scientific meeting. - OEMs and vendors: No commercial OEMs, vendors, or specific products are named. No quantities or part numbers are specified.

Description

Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.

View original listing